Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
A single eye just became ground zero for one of science's biggest bets on turning back the clock on aging. Boston-based Life ...
NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...
Paper in Cloning and Stem Cells shows that animal eggs do not support specific reprogramming toward the normal human embryonic state. Investigators at Advanced Cell Technology (ACTC) have found that ...